Deutsche Bank AG reduced its position in agilon health, inc. (NYSE:AGL – Free Report) by 42.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,205,026 shares of the company’s stock after selling 882,390 shares during the quarter. Deutsche Bank AG owned approximately 0.29% of agilon health worth $2,290,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Inspire Investing LLC increased its holdings in agilon health by 106.6% in the 4th quarter. Inspire Investing LLC now owns 217,550 shares of the company’s stock valued at $413,000 after buying an additional 112,241 shares during the period. Price T Rowe Associates Inc. MD boosted its position in shares of agilon health by 41.0% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 338,529 shares of the company’s stock valued at $644,000 after acquiring an additional 98,377 shares in the last quarter. Cerity Partners LLC acquired a new stake in shares of agilon health during the 4th quarter valued at about $34,000. MetLife Investment Management LLC increased its stake in agilon health by 4.0% in the fourth quarter. MetLife Investment Management LLC now owns 174,551 shares of the company’s stock valued at $332,000 after acquiring an additional 6,762 shares during the period. Finally, Geode Capital Management LLC raised its position in agilon health by 0.5% in the fourth quarter. Geode Capital Management LLC now owns 6,928,724 shares of the company’s stock worth $13,168,000 after purchasing an additional 35,207 shares in the last quarter.
Analyst Upgrades and Downgrades
A number of research analysts have commented on the stock. Sanford C. Bernstein upgraded shares of agilon health from a “market perform” rating to an “outperform” rating and raised their price target for the stock from $3.30 to $8.50 in a research note on Tuesday, April 8th. Royal Bank of Canada increased their target price on agilon health from $3.00 to $3.50 and gave the stock an “outperform” rating in a report on Wednesday, February 26th. TD Cowen boosted their price target on agilon health from $3.50 to $6.00 and gave the company a “hold” rating in a research note on Tuesday, April 15th. The Goldman Sachs Group upped their price target on agilon health from $2.50 to $5.00 and gave the company a “neutral” rating in a research report on Thursday, May 8th. Finally, Stifel Nicolaus lifted their price objective on agilon health from $2.00 to $3.00 and gave the company a “hold” rating in a report on Wednesday, February 26th. Two analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $4.90.
agilon health Price Performance
Shares of AGL stock opened at $2.21 on Friday. The stock’s fifty day moving average is $4.04 and its 200-day moving average is $3.18. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The stock has a market capitalization of $914.83 million, a PE ratio of -2.35 and a beta of 0.38. agilon health, inc. has a 52 week low of $1.50 and a 52 week high of $7.73.
agilon health (NYSE:AGL – Get Free Report) last issued its quarterly earnings results on Tuesday, May 6th. The company reported $0.03 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.01) by $0.04. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The business had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.50 billion. During the same quarter in the prior year, the company earned ($0.02) EPS. The firm’s quarterly revenue was down 4.5% on a year-over-year basis. Equities research analysts expect that agilon health, inc. will post -0.59 EPS for the current fiscal year.
About agilon health
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Read More
- Five stocks we like better than agilon health
- Dividend Capture Strategy: What You Need to Know
- Turbulence for Joby Shares: What’s Behind the Recent Dip?
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Why Carnival Could Be the Ultimate Non-Tech Growth Stock
- NYSE Stocks Give Investors a Variety of Quality OptionsĀ
- Super Micro Computer Stock Clears New Path Higher on Saudi Orders
Want to see what other hedge funds are holding AGL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for agilon health, inc. (NYSE:AGL – Free Report).
Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.